{"id":"azithromycin-1gm","safety":{"commonSideEffects":[{"rate":"3-5","effect":"Nausea"},{"rate":"5-7","effect":"Diarrhea"},{"rate":"2-4","effect":"Abdominal pain"},{"rate":"1-3","effect":"Vomiting"},{"rate":null,"effect":"QT prolongation"},{"rate":null,"effect":"Hepatotoxicity"}]},"_chembl":{"chemblId":"CHEMBL4299381","moleculeType":"Small molecule","molecularWeight":"749.00"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Azithromycin is a macrolide antibiotic that binds irreversibly to the bacterial 50S ribosomal subunit, blocking the translocation of peptides and inhibiting protein synthesis. This bacteriostatic action prevents bacterial replication and allows the immune system to clear the infection. It has broad-spectrum activity against many gram-positive and gram-negative bacteria, as well as atypical organisms.","oneSentence":"Azithromycin inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, preventing peptide bond formation and halting bacterial growth.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:27:59.705Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Community-acquired pneumonia"},{"name":"Acute bacterial sinusitis"},{"name":"Acute otitis media"},{"name":"Pharyngitis/tonsillitis"},{"name":"Uncomplicated skin and soft tissue infections"},{"name":"Sexually transmitted infections (Chlamydia trachomatis, Neisseria gonorrhoeae)"}]},"trialDetails":[{"nctId":"NCT04349826","phase":"PHASE4","title":"The Azithromycin and Cefixime Treatment of Typhoid in South Asia Trial (ACT-South Asia Trial)","status":"COMPLETED","sponsor":"Oxford University Clinical Research Unit, Vietnam","startDate":"2021-05-23","conditions":"Typhoid Fever","enrollment":2150},{"nctId":"NCT03570814","phase":"PHASE4","title":"Cluster RCT of Co-administration Azithromycin, Albendazole & Ivermectin","status":"COMPLETED","sponsor":"London School of Hygiene and Tropical Medicine","startDate":"2021-12-01","conditions":"Trachoma, Lymphatic Filariases","enrollment":13511},{"nctId":"NCT04937569","phase":"PHASE3","title":"Ivermectin Versus Standard Treatment in Mild COVID-19","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2021-07-01","conditions":"Covid19","enrollment":1644},{"nctId":"NCT04323345","phase":"PHASE3","title":"Efficacy of Natural Honey Treatment in Patients With Novel Coronavirus","status":"UNKNOWN","sponsor":"Misr University for Science and Technology","startDate":"2020-04-15","conditions":"COVID-19","enrollment":1000},{"nctId":"NCT03233880","phase":"PHASE4","title":"Impact of Antichlamydial Treatment on the Rate of Preeclampsia","status":"UNKNOWN","sponsor":"Ain Shams Maternity Hospital","startDate":"2016-07-01","conditions":"Pre-Eclampsia","enrollment":1200},{"nctId":"NCT02830230","phase":"NA","title":"\"Performance of HPV DNA Test in Presence of Co-infection With Common RTIs\"","status":"UNKNOWN","sponsor":"Tata Memorial Hospital","startDate":"2016-07","conditions":"Cervical Inflammation and Human Papilloma Virus Performance","enrollment":508},{"nctId":"NCT01431248","phase":"","title":"PPROM Erythromycin Versus Azithromycin","status":"COMPLETED","sponsor":"University of Oklahoma","startDate":"2011-09","conditions":"Preterm Premature Rupture of Membranes","enrollment":7},{"nctId":"NCT00805545","phase":"NA","title":"Timing of Antibiotic Prophylaxis for Cesarean Deliveries","status":"COMPLETED","sponsor":"University of Florida","startDate":"2008-11","conditions":"Infection","enrollment":400}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["anti chlamydial treatment"],"phase":"marketed","status":"active","brandName":"Azithromycin 1gm","genericName":"Azithromycin 1gm","companyName":"Ain Shams Maternity Hospital","companyId":"ain-shams-maternity-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Azithromycin inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, preventing peptide bond formation and halting bacterial growth. Used for Community-acquired pneumonia, Acute bacterial sinusitis, Acute otitis media.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}